Ratings Modern Dental Group Limited

Equities

3600

KYG618201092

Market Closed - Hong Kong S.E. Other stock markets 04:08:27 2024-07-12 am EDT			5-day change	1st Jan Change
4.11 ^HKD	+1.48%		-2.38%	-4.42%

Jun. 12	Modern Dental Group Limited commences an Equity Buyback for 94,839,800 shares, representing 10% of its issued share capital, under the authorization approved on May 30, 2024.	CI
May. 31	Modern Dental's Revenue, Sales Volume Rise in Q1	MT

Strengths

The company returns high margins, thereby supporting business profitability.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
Given the positive cash flows generated by its business, the company's valuation level is an asset.
The company is one of the best yield companies with high dividend expectations.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Over the past four months, analysts' average price target has been revised upwards significantly.

Weaknesses

For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
Revenue estimates are regularly revised downwards for the current and coming years.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
MODERN DENTAL GROUP LIMITED	-4.42%	498M		-
STRAUMANN HOLDING AG	-13.24%	20.98B		B
SONOVA HOLDING AG	+1.06%	18.49B		A
COCHLEAR LIMITED	+9.82%	14.59B		B
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.	-27.45%	1.81B		-
EMBLA MEDICAL HF.	+4.55%	1.79B		B+
ANGELALIGN TECHNOLOGY INC.	+7.16%	1.31B		D-
ANGEL ROBOTICS CO., LTD.	0.00%	355M	-	-
DELCATH SYSTEMS, INC.	+93.99%	224M		-
INTEGRUM AB	+22.23%	103M		-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes